Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |